EE05620B1 - Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid - Google Patents

Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid

Info

Publication number
EE05620B1
EE05620B1 EEP200000466A EEP200000466A EE05620B1 EE 05620 B1 EE05620 B1 EE 05620B1 EE P200000466 A EEP200000466 A EE P200000466A EE P200000466 A EEP200000466 A EE P200000466A EE 05620 B1 EE05620 B1 EE 05620B1
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical preparations
omeprazole
omeprazole microgranules
microgranules
Prior art date
Application number
EEP200000466A
Other languages
English (en)
Estonian (et)
Inventor
Debregeas Patrice
Leduc G�rard
Oury Pascal
Suplie Pascal
Original Assignee
Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9522415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05620(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm filed Critical Ethypharm
Publication of EE200000466A publication Critical patent/EE200000466A/xx
Publication of EE05620B1 publication Critical patent/EE05620B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EEP200000466A 1998-01-30 1998-08-10 Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid EE05620B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9801098A FR2774288B1 (fr) 1998-01-30 1998-01-30 Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
PCT/FR1998/001783 WO1999038511A1 (fr) 1998-01-30 1998-08-10 Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques

Publications (2)

Publication Number Publication Date
EE200000466A EE200000466A (et) 2002-04-15
EE05620B1 true EE05620B1 (et) 2013-02-15

Family

ID=9522415

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000466A EE05620B1 (et) 1998-01-30 1998-08-10 Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid

Country Status (32)

Country Link
US (1) US6551621B1 (pt)
EP (1) EP1051174B2 (pt)
JP (1) JP4286452B2 (pt)
KR (1) KR100510366B1 (pt)
CN (1) CN1114405C (pt)
AT (1) ATE232100T1 (pt)
AU (1) AU755882B2 (pt)
BG (1) BG65087B1 (pt)
BR (1) BR9814924B1 (pt)
CA (1) CA2319015C (pt)
CZ (1) CZ299192B6 (pt)
DE (1) DE69811278T3 (pt)
DK (1) DK1051174T4 (pt)
EA (1) EA002879B1 (pt)
EE (1) EE05620B1 (pt)
ES (1) ES2189232T5 (pt)
FR (1) FR2774288B1 (pt)
GE (1) GEP20032941B (pt)
HK (1) HK1032354A1 (pt)
HU (1) HU229956B1 (pt)
IL (1) IL137536A0 (pt)
IS (1) IS2866B (pt)
NO (1) NO330144B1 (pt)
NZ (1) NZ505998A (pt)
PL (1) PL200043B1 (pt)
PT (1) PT1051174E (pt)
RS (1) RS50245B (pt)
SI (1) SI1051174T2 (pt)
SK (1) SK285666B6 (pt)
TR (1) TR200002214T2 (pt)
UA (1) UA61988C2 (pt)
WO (1) WO1999038511A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
EP1603537A4 (en) * 2003-02-20 2009-11-04 Santarus Inc IMMEDIATE RELEASE OF OMEPRAZOLE ANTACIDAL COMPLEX WITH NEW FORMULATION FOR RAPID AND PROLONGED ELIMINATION OF GASTRIC ACID
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2006528181A (ja) * 2003-07-18 2006-12-14 サンタラス インコーポレイティッド 酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法
AU2004257864A1 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
JP5171038B2 (ja) * 2003-10-10 2013-03-27 エティファルム イチョウ・エキスを含む放出持続性の微小顆粒およびそのような顆粒の製造方法
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
JP2007522217A (ja) * 2004-02-10 2007-08-09 サンタラス インコーポレイティッド プロトンポンプ阻害剤、緩衝剤および非ステロイド系抗炎症薬の組み合わせ
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP5563735B2 (ja) * 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
WO2007115305A2 (en) 2006-04-04 2007-10-11 Cogentus Pharmaceuticals, Inc. Oral dosage forms including an antiplatelet agent and an acid inhibitor
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2081546A2 (en) * 2006-10-17 2009-07-29 Ranbaxy Laboratories Limited Multiple unit tablet compositions of benzimidazole compounds
CA2860231A1 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
EP3117824A1 (en) 2015-07-17 2017-01-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
AU2016294734B2 (en) 2015-07-17 2021-01-28 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
FR3078630B1 (fr) 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (ja) * 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
DE69527364T2 (de) * 1994-09-30 2003-03-13 Medical Security Corp., Portland Verfahren zum reinigen und rutschfesten behandlung von oberflächenbelägen
ES2094694B1 (es) † 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
CH687810A5 (de) 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
DE69631981T2 (de) * 1995-09-21 2005-04-14 Pharma Pass Ii Llc, Irvine Lansoprazolhaltige Arzneizusammensetzung und Herstellungsverfahren
EP0941074B1 (en) * 1996-11-06 2004-07-21 Wockhardt Europe Limited Delayed delivery system for acid-sensitive drugs
GB9710800D0 (en) * 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II

Also Published As

Publication number Publication date
YU48400A (sh) 2003-02-28
BR9814924A (pt) 2000-10-17
RS50245B (sr) 2009-07-15
KR20010040502A (ko) 2001-05-15
FR2774288B1 (fr) 2001-09-07
CZ299192B6 (cs) 2008-05-14
IL137536A0 (en) 2001-07-24
PL200043B1 (pl) 2008-11-28
UA61988C2 (uk) 2003-12-15
AU9074898A (en) 1999-08-16
HU229956B1 (hu) 2015-03-02
BG65087B1 (bg) 2007-02-28
EE200000466A (et) 2002-04-15
CA2319015A1 (fr) 1999-08-05
NO330144B1 (no) 2011-02-21
DE69811278T3 (de) 2012-11-29
BG104634A (bg) 2001-02-28
IS2866B (is) 2014-01-15
PL342044A1 (en) 2001-05-21
JP4286452B2 (ja) 2009-07-01
ES2189232T3 (es) 2003-07-01
CA2319015C (fr) 2008-08-05
SK11412000A3 (sk) 2001-04-09
ES2189232T5 (es) 2012-11-07
SI1051174T2 (sl) 2013-01-31
EP1051174B1 (fr) 2003-02-05
HUP0100347A3 (en) 2002-12-28
HK1032354A1 (en) 2001-07-20
EP1051174B2 (fr) 2012-07-04
CN1284877A (zh) 2001-02-21
TR200002214T2 (tr) 2000-12-21
EA200000797A1 (ru) 2001-02-26
SK285666B6 (sk) 2007-05-03
PT1051174E (pt) 2003-06-30
WO1999038511A1 (fr) 1999-08-05
CN1114405C (zh) 2003-07-16
NZ505998A (en) 2003-11-28
FR2774288A1 (fr) 1999-08-06
CZ20002709A3 (cs) 2000-12-13
DK1051174T3 (da) 2003-05-26
BR9814924B1 (pt) 2010-07-13
EA002879B1 (ru) 2002-10-31
EP1051174A1 (fr) 2000-11-15
DK1051174T4 (da) 2012-10-01
NO20004654L (no) 2000-09-18
ATE232100T1 (de) 2003-02-15
KR100510366B1 (ko) 2005-08-24
GEP20032941B (en) 2003-04-25
IS5577A (is) 2000-07-25
US6551621B1 (en) 2003-04-22
NO20004654D0 (no) 2000-09-18
DE69811278D1 (de) 2003-03-13
HUP0100347A2 (hu) 2001-10-28
SI1051174T1 (en) 2003-06-30
AU755882B2 (en) 2003-01-02
JP2002501895A (ja) 2002-01-22
DE69811278T2 (de) 2003-11-27

Similar Documents

Publication Publication Date Title
EE05620B1 (et) Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid
EE04576B1 (et) Suposiit happes ebapüsivate toimeainete tarbeks, selle valmistamismeetod, toimeaineühik ja selle valmistamismeetod ning preparaat
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
DE69830095D1 (de) Pharmazeutischer, kosmetischer oder dermo-pharmazeutischer Patch zur Verabreichung mehrerer verschiedenartiger Aktivstoffe
ITRM920928A0 (it) Eliminatore di ossigeno attivo e preparato farmaceutico che lo contiene.
DE59804823D1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
DE50003454D1 (de) Proteinenthaltende pharmazeutische zubereitung
ATE187890T1 (de) Ligandgerichtete enzyme-prodrug therapie
WO1997026867A3 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
PT1200071E (pt) Comprimidos fracamente doseados e processo de preparacao
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
UY24489A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimiento para su preparación y aplicación de estos compuestos en medicamentos.
ECSP972055A (es) Compuestos de dimetil (3-aril-but-3-enil)- amina, procedimientos para su preparacion y aplicación de estos compuestos en medicamentos
DE69834434D1 (de) Verbindung und Arzneizusammensetzung zur Verabreichung von Wirkstoffen
FI991115A0 (fi) Menetelmä oraalisesti elimistöön tuotavan ravinteen tai muun fysiologisesti vaikuttavan aineen maittavuuden biokyberneettiseksi manipuloimiseksi sekä menetelmän käyttämiseen liittyvä valmiste